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Research
Pyrethroids are synthetic insecticides derived 
from pyrethrins (Casida 1980; Elliott 1978). 
Pyrethroids are increasingly used in a wide 
array of pesticide applications, including 
veteri  nary, agriculture, and home pest control 
(Amweg et al. 2005). Recent reports indicate 
low-level exposure to multiple pyrethroids 
in humans (Becker et al. 2006; Fortin et al. 
2008; Heudorf et al. 2004; Lu et al. 2006, 
2009; Morgan et al. 2007; Riederer et al. 
2008; Tulve et al. 2006). Pyrethroids have 
been classified as type I or type II based on 
acute high-dose biological effects and chemical 
structure (Gammon et al. 1981; Gray 1985; 
Lawrence and Casida 1982; Verschoyle and 
Aldridge 1972, 1980). Type I compounds lack 
an α-cyano group on the phenoxy  benzyl moi-
ety and produce toxic signs charac  terized by 
aggressive sparring and tremors (T syndrome). 
Type II compounds contain an α-cyano group 
on the phenoxybenzyl moiety, and acute expo-
sures produce a syndrome characterized by 
choreoathetosis and salivation (CS syndrome). 
A limited number of pyrethroids elicit both 
tremors and salivation (Gammon et al. 1981; 
Lawrence and Casida 1982; Verschoyle and 
Aldridge 1980) and have been classified as 
type I/II or TS syndrome compounds.
The Food Quality Protection Act (FQPA 
1996) requires the U.S. Environmental 
Protection Agency (EPA) to consider the 
cumulative risk of chemicals having a common 
“mechanism of toxicity.” For chemicals consid-
ered to have a common mechanism of toxicity 
(commonality of target tissue, target site, and 
primary toxicologic effects for the members of 
a chemical class), dose additivity is the default 
hypothe  sis for assessing the hazard of mixtures 
(U.S. EPA 1999, 2002a). The overall assump-
tion under dose additivity is that the toxicity 
of each component of the mixture behaves 
as a known dilution of a reference chemical 
selected as the index compound (U.S. EPA 
2000). This approach was used for the cumula-
tive risk assessment of cholinesterase-inhibiting 
organo  phosphate (U.S. EPA 2002b) and car-
bamate (U.S. EPA 2007) pesticides. The pres-
ent study was part of a larger research effort to 
determine whether or not pyrethroid pesticides 
share a common mechanism and may thus be 
subject to cumulative risk assessment.
Pyrethroids act primarily on the nervous 
system (Narahashi 2000; Soderlund et al. 
2002). A proposed mechanism of action for 
all pyrethroids is the prolongation of the open 
state of neuronal voltage-dependent sodium 
channels (Narahashi 1971; Vijverberg and 
van den Bercken 1990). This action results in 
altered neuronal excitability characterized by 
in vitro and in vivo changes in neuronal fir-
ing rates (e.g., repetitive firing or depolarizing 
block of the neuron) (Narahashi 2000) that 
are associated with two high-dose neuro  logic 
syndromes, T syndrome and the CS syndrome 
(Aldridge 1990; Barnes and Verschoyle 1974; 
Lawrence and Casida 1982; Ray and Forshaw 
2000; Ray and Fry 2006; Verschoyle and 
Aldridge 1980), and dose-dependent changes 
in motor and sensory behaviors at lower doses 
(Chanh et al. 1984; Crofton and Reiter 1984 
1988; Hornychova et al. 1995; McDaniel and 
Moser 1993; Nishimura et al. 1984; Wolansky 
et al. 2006; Wolansky and Harrill 2008).
Currently, the link between alterations 
in neuronal firing and downstream neuro-
behavioral syndromes is correlative and not 
causative. Mechanistic pathways linking sites 
of action (e.g., sodium channels) to neurologic 
outcomes have not been fully elucidated (Gray 
1985; Ray and Fry 2006; Shafer et al. 2005; 
Soderlund et al. 2002). This has resulted in 
uncertainty about whether a common mecha-
nism of toxicity exists for all pyrethroids 
(Soderlund et al. 2002). Pyrethroid actions 
on many other neuronal target sites have been 
reported and include calcium (Ca++), potassium 
(K+), and chloride (Cl–) channels (Burr and 
Ray 2004; Lawrence and Casida 1982; Ray and 
Fry 2006; Shafer and Meyer 2004). Although 
those mechanisms of action are not as well 
established (Shafer and Meyer 2004) as actions 
on Na+ channels, alterations in these ion chan-
nels will also disrupt neuronal firing rates.
No published data exist to determine 
whether dose addition predicts the effects 
of the combined exposure to pyrethroids 
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Ba c k g r o u n d: Pyrethroids are neurotoxic insecticides used in a variety of indoor and outdoor 
  applications. Previous research characterized the acute dose–effect functions for 11 pyrethroids 
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oBjectives: We used a mixture of these 11 pyrethroids and the same testing paradigm used in 
single-compound assays to test the hypothesis that cumulative neurotoxic effects of pyrethroid mix-
tures can be predicted using the default dose–addition theory.
Me t h o d s : Mixing ratios of the 11 pyrethroids in the tested mixture were based on the ED30 (effec-
tive dose that produces a 30% decrease in response) of the individual chemical (i.e., the mixture 
comprised equi  potent amounts of each pyrethroid). The highest concentration of each individual 
chemical in the mixture was less than the threshold for inducing behavioral effects. Adult male rats 
received acute oral exposure to corn oil (control) or dilutions of the stock mixture solution. The 
mixture of 11 pyrethroids was administered either simultaneously (2 hr before testing) or after a 
sequence based on times of peak effect for the individual chemicals (4, 2, and 1 hr before testing). A 
threshold additivity model was fit to the single-chemical data to predict the theoretical dose–effect 
relationship for the mixture under the assumption of dose additivity.
re s u l t s: When subthreshold doses of individual chemicals were combined in the mixtures, we 
found significant dose-related decreases in motor activity. Further, we found no departure from the 
predicted dose-additive curve regardless of the mixture dosing protocol used.
co n c l u s i o n: In this article we present the first in vivo evidence on pyrethroid cumulative effects 
supporting the default assumption of dose addition. 
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in mammals. Some in vitro evidence on 
the action of pyrethroid mixtures has been 
reported. Whole-cell and patch-clamp assays 
in cultured neurons from rat suggest that 
type I and type II pyrethroids interact with 
Na+ channel binding sites by either com-
petitive or allo  steric actions (Motomura and 
Narahashi 2001; Song and Narahashi 1996). 
In addition, structure-dependent inter  action 
among pyrethroids has been proposed to 
occur in Cl– channels: pretreatment with cis-
resmethrin (type I) antagonizes the effects of 
fenpropathrin, a mixed type I/II pyrethroid 
(Burr and Ray 2004). Unfortunately, these 
studies were not designed to test the hypoth-
esis of dose addition (Burr and Ray 2004). 
Soderlund et al. (2002) highlighted the need 
for empirical data to test the hypothesis of 
additivity for pyrethroids using robust statisti-
cal models (e.g., Casey et al. 2004; Feron and 
Groten 2002; Olmstead and LeBlanc 2005).
In the present study, we tested the hypoth-
esis that pyrethroids act in a dose-additive 
manner. The hypothesis was tested using the 
“single-chemical-required” (SCR) method 
(Casey et al. 2004) that compares a thresh-
old additivity model (Gennings et al. 2004), 
fit to single-compound data, with a similarly 
parameterized model for data obtained from 
an experimentally tested mixture. We used 
motor activity as the dependent variable in 
this study for two reasons. First, motor activity 
is a valid test method routinely used in acute 
and sub  chronic regulatory neuro  toxicity stud-
ies [Organization for European Cooperation 
and Development (OECD) 1997, 2007; 
Soderlund 2001; Soderlund et al. 2002; U.S. 
EPA 1998a, 1998b). Second, motor activity 
has been extensively evaluated for a number of 
pyrethroids in rodents. Seventeen pyrethroid 
preparations, assessed under a variety of dosing 
and testing conditions across laboratories, pro-
duced decreased activity (Crofton et al. 1995; 
Crofton and Reiter 1984, 1988; De Souza 
Spinosa et al. 1999; Hornychova et al. 1995; 
Hoy et al. 2000; Mandhane and Chopde 
1997; McDaniel and Moser 1993; Reiter 
et al. 1981; Righi and Palermo-Neto 2003; 
Wolansky et al. 2006). In addition, recent 
research has characterized extensive dose–effect 
functions for 11 pyrethroids on motor activ-
ity. Data from these 11 compounds were used 
to compute ED30 values (dose that decreases 
activity by 30%) and relative potencies 
(Wolansky et al. 2006). In the present study, 
we used a mixture of these 11 pyrethroids to 
test the hypothesis of dose addition.
We also tested the hypothesis that 
kinetic differences between the 11 pyre-
throids would result in less than dose addi-
tion if all compounds were administered at 
once. Toxicokinetic differences for individual 
pyrethroids result in variation in the time 
of peak effects of more than 4 hr for the 11 
pyrethroids tested (Soderlund et al. 2002; 
Wolansky et al. 2006; Wolansky and Harrill 
2008). To test this hypothesis, we used two 
alternative oral dosing protocols: simultaneous 
(SLT) adminis  tration of all chemicals with 
a 2-hr dose-to-test interval, and a sequential 
(SQT) protocol where the 11 compounds 
were administered either 1, 2, or 4 hr before 
testing, depending on each chemical’s time of 
peak effect. In addition, we conducted a time 
course study to determine the time of peak 
effect for the mixture when administered using 
the SLT protocol. The empirical mixture data 
for both the SLT and SQT exposure protocols 
were fit to a threshold dose–  response curve 
and compared with the theoretical outcome 
predicted by the additivity model using the 
SCR method of analysis [modeling procedures 
described by Casey et al. (2004)].
Materials and Methods
Subjects. Male Long-Evans rats (Charles River 
Laboratories Inc., Wilmington, MA, USA) 
were obtained at 55–57 days of age and housed 
two per cage in standard polycarbonate hang-
ing cages (45 cm × 24 cm × 20 cm) contain-
ing heat-sterilized pine shavings (Beta Chips; 
Northeastern Products, Inc., Warrensburg, 
NY, USA). All animals were given a 5- to 
9-day acclimation period and were maintained 
on a 12:12-hr photo  period (0600:1800 hours). 
Food (Purina 5001 Lab Chow; Ralston-Purina, 
St. Louis, MO, USA) and tap water were 
provided ad libitum. Tap water (city water; 
Durham, NC, USA) was filtered through 
sand and activated charcoal filters and then 
rechlorinated to 4–5 ppm Cl– before use. 
Colony rooms were maintained at 22 ± 2°C 
and relative humidity at 55 ± 20%. The facil-
ity is approved by the American Association 
for Accreditation of Laboratory Animal Care. 
All animals were treated humanely and with 
regard to alleviation of suffering. All experi-
mental protocols were approved in advance 
by the National Health and Environmental 
Effects Research Laboratory’s Animal Care and 
Use Committee.
Chemicals. Technical grade samples of 
pyrethroids were kindly supplied by their 
manu  facturers: permethrin, bifenthrin, 
and cypermethrin (FMC Corporation, 
Philadelphia, PA, USA); esfenvalerate 
(Dupont Crop Protection, Wilmington, DE, 
USA); deltamethrin and β-cyfluthrin (Bayer 
CropScience LP, Research Triangle Park, NC, 
USA); tefluthrin and λ-cyhalothrin (Syngenta 
Crop Protection, Greensboro, NC, USA); and 
fenpropathrin, resmethrin, and S-bioallethrin 
(Valent USA Corp., Walnut Creek, CA, 
USA). Information on the chemical purity and 
isomer composition was reported previously 
(Wolansky et al. 2006). Doses were calcu-
lated based on percent active ingredient in the 
technical product. Mixture stock and dosing 
solutions were prepared daily by codissolving 
pyrethroids in corn oil (Sigma Chemical Co., 
St. Louis, MO, USA) according to the dos-
ing protocol described below. Solutions were 
stirred and gently heated (40–50°C) before 
dosing to assure full solubility and then used 
at room temperature.
Mixture composition. The fixed ratio 
of individual pyrethroids in the stock solu-
tion (i.e., ai proportion; for each chemical i, 
ai = dosei/dosemixture) was based on the indi-
vidual relative potency factors (RPFs) obtained 
from single-compound assays (Wolansky 
et al. 2006). Each RPF was calculated as the 
ratio of the ED30 for the index compound 
(i.e., ED30 for delta  methrin = 2.50 mg/kg) 
divided by the ED30 for each chemical. The 
ED30 was chosen as a biologically signifi-
cant effect on motor activity (Crofton et al. 
1991). The absolute doses of each chemical 
in the stock solution (i.e., the highest mixture 
dose examined) were equal to 33% of the 
ED30 for the chemical [see also Supplemental 
Material, Table 1 (doi:10.1289/ehp.0900667.
S1 via http://dx.doi.org/)]. This dose is 
approximately 20% lower than the thresh-
old dose previously calculated using the SCR 
approach on each individual dose–effect data 
set (Wolansky et al. 2006). Table 1 lists the 
chemical names, potency information (derived 
Table 1. Summary of pyrethroid type, threshold dose, ED30, percentage of total mixture dose mass, and 
the absolute dose for each chemical.
Pyrethroid  Type Thresholda (mg/kg) ED30
a (mg/kg)
Percent total 
mixture dose 
Pyrethroid dose (mg/kg) 
in stock mixture
β-Cyfluthrin II 0.88 2.21 0.49 0.74
Bifenthrin I 1.28 3.21 0.70 1.07
S-Bioallethrin I 36.02 90.48 19.82 30.2
Cypermethrin II 4.26 10.70 2.34 3.57
Deltamethrin II 0.99 2.51 0.55 0.84
Esfenvalerate II 0.48 1.20 0.26 0.40
Fenpropathrin I/II 3.06 7.70 1.69 2.57
λ-Cyhalothrin II 0.52 1.32 0.29 0.44
Permethrin I 16.99 42.66 9.31 14.2
Resmethrin I 116.60 292.80 64.10 97.6
Tefluthrin I 0.90 2.26 0.49 0.75
The fixed mixing ratio was based on the ratio of the ED30 for the each chemical compared with an index compound (i.e., 
ED30 for deltamethrin = 2.50 mg/kg). 
aData from Wolansky et al. (2006).Pyrethroids and mixtures
Environmental Health Perspectives  •  v o l u m e  117 | n u m b e r 10 | October 2009  1565
from Wolansky et al. 2006), mixing ratios, 
and stock mixture solution composition. Two 
sets of stock solutions were made. Stock A 
contained all 11 chemicals in the ratio and 
amounts described above. The second set, 
used for the sequential dosing, consisted of 
three separate stocks: Stock B1 contained 
S-bioallethrin only; stock B2 contained per-
methrin, cypermethrin, delta  methrin, esfenva-
lerate, β-cyfluthrin, fenpro  pathrin, tefluthrin, 
and λ-cyhalothrin; and stock B3 contained 
bifenthrin and resmethrin [see Supplemental 
Material, Table 2 (doi:10.1289/ehp.0900667.
S1)]. The overall ratio and composition of 
stocks B1, B2, and B3 were equivalent to 
stock A. All dosing solutions were made daily. 
Exposure. Before dosing, animals were 
moved from the colony room to an iso-
lated dosing room within the testing labora-
tory. After a 1-hr acclimation, animals were 
removed from home cages, dosed, and then 
returned to the home cages until the next 
dosing time or testing. All rats were ran-
domly assigned to treatment groups. Body 
weights were counter  balanced across groups. 
Experimentally naive groups of rats were used 
for each experiment. Dose selection for the 
dose–response studies was based on pilot work 
(data not shown), with the goal to identify at 
least two no-effect levels.
We used vehicle control and two dose 
  levels for the mixture time-course study: 
0 (corn oil only), 76, and 152 mg pyrethroid/
kg. The two doses were chosen to produce 
mild and moderate clinical signs of pyrethroid 
exposure. The high dose produced mild tremor 
in most of the animals that lasted from 1 to 
4 hr, whereas the lower dose produced a small 
percentage of animals exhibiting transient bur-
rowing and pawing behaviors but no tremor. 
Independent groups of animals were exposed 
for 1, 2, 4, 8, 24, or 48 hr before testing (n = 8 
or 12 per group, except at 48 hr, n = 4 for the 
76 mg/kg/group).
We used two experimental designs for 
the dose response that differed only in the 
dosing protocol used to administer all the 
chemicals. The SLT protocol used mixture 
stock A, whereby all 11 pyrethroids were 
administered at the same time in one mixture 
2 hr before testing (three replicate test blocks 
with four rats per mixture dose per block). 
The 2-hr time point was based on the time of 
peak effect of the mixture determined in the 
time-course study. The SQT protocol used 
mixture stocks B1, B2, and B3 (two replicate 
test blocks with six rats per mixture dose per 
block). Because of known differences in the 
kinetics and time course of effects of the differ-
ent pyrethroids, this protocol allowed sequen-
tial dosing where the 11 pyrethroids were 
adminis  tered according to their previously 
determined time of peak effects (Table 2). 
The time between dosing and testing for the 
three mixture stocks and dilutions were 1 hr 
for stock B1, 2 hr for stock B2, and 4 hr for 
stock B3. Seven mixture dosages, from 1% to 
100% of the concentration of the stock solu-
tion, were tested in each dose–response experi-
ment as follows: SLT protocol, 1%, 4%, 10%, 
33%, 50%, 66%, and 100%; SQT protocol, 
1%, 4%, 20%, 30%, 40%, 50%, and 100%.
Motor activity testing. The same end 
point and testing procedures used in single-
compound assessments (Wolansky et al. 2006) 
were used to examine mixture dose–effect 
relationships. Rats were transferred from the 
holding room to the adjacent testing room in 
individual polycarbonate transfer cages and 
were allowed to acclimate for 5 min before test-
ing. Motor activity was then measured for 1 hr 
using 16 figure-eight mazes, each consisting of 
a series of inter  connected alleys (10 × 10 cm) 
converging on a central arena and covered 
with trans  parent acrylic plastic (Norton et al. 
1975; Reiter et al. 1975). Total activity was 
calculated as the sum of horizontal and vertical 
activity photo  cell counts. Photobeam calibra-
tion was checked daily before testing. Maze 
assignments, order of testing, and time of day 
were counterbalanced across treatment groups. 
All testing was conducted between 0900 and 
1700 hours.
Statistical analysis. We analyzed motor 
activity data (i.e., total photocell counts for 
the 1-hr test session) by two-way analysis of 
variance (ANOVA) using SAS software ver-
sion 9.1 (SAS Institute Inc., Cary, NC, USA), 
with mixture dose and time as independent 
variables. For the SQT and SLT mixture-dose 
studies, a two-way ANOVA was used, with 
block and mixture-dose treatment as inde-
pendent variables and total activity counts as 
the dependent variable. We performed mean 
contrast testing using Duncan’s new mul-
tiple range test (SAS). Data from one test-
ing run in the time-course study (n = 8 rats) 
were excluded from formal analysis because 
of excessive noise from building construction. 
In addition, one rat was excluded because 
of excessive toxicity (8 hr, high dose). In the 
SLT experiment, data from one rat (1.5 mg/
kg), and in the SQT experiment data from 
three rats (one each from the 1.5, 30.5, and 
76.2 mg/kg groups), were excluded because of 
aspiration of the gavage fluid into the lungs.
Determination of departure from additivity 
for the motor activity data from two mixture 
dose–response studies (SLT and SQT proto-
cols) used the SCR method. The definition 
of additivity given by Berenbaum (1985) can 
be related to the isobologram for a combina-
tion of chemicals (Loewe 1953; Loewe and 
Muischnek 1926) through the inter  action 
index. That is, in a combination of c (here, 
c = 11) chemicals, Ei represents the concen-
tration or dose of the ith component alone 
that yields a fixed response (i.e., ED30), and 
xi represents the concentration/dose of the ith 
component in combination with the c agents 
that yield the same response. According to this 
definition, if the substances interact in an addi-
tive fashion, then
  E
x
1
i
i
i
c
1
=
=
/ .  [1]
If the left-hand side of Equation 1, termed 
the “interaction index,” is < 1, then a greater 
than additive inter  action (e.g., synergism) can 
be claimed at the combination of interest. If 
the left-hand side of Equation 1 is > 1, then a 
less than additive interaction (e.g., antagonism) 
can be claimed with the combination. This 
definition of additivity is a general form for 
dose addition. It should be pointed out that 
use of the toxic equivalence factor approach 
(Safe 1998) assumes common dose–response 
slopes across the chemicals under study; the 
general dose-addition definition of Equation 1 
does not require such an assumption.
We combined the 11 chemicals according 
to the specified mixing ratio (Table 1) and 
evaluated them experimentally. The mixing 
ratio is denoted in terms of the proportion, ai, 
of each chemical in the mixture (Table 1) such 
that the summation of ai for the 11 chemicals 
equals 1, and the dose xi of each chemical in 
the mixture is
xi = ait (i.e., total mixture dose = t = 
11
Σ
i = 1 
xi).
The SCR approach (Casey et al. 2004) 
allows for different slope parameters for each 
chemical and fixed-ratio mixture. The single-
chemical data were modeled (termed the addi-
tivity model) using a nonlinear exponential 
threshold model for the mean motor activity 
(percent of control) of the form
µ =
a c +
≤ x x
x >
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i i
i
i i
i
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where α + γ = 100, α is the maximum effect 
parameter, xi is the absolute dose of the ith 
chemical, βi are the slope parameters for the 
Table 2. Individual times to peak effect and the 
mixture dosing protocols for each chemical. 
Individual 
time to peak 
effect (hr)
Mixture dosing protocol  
(hours before testing)
Compound SLT dosing SQT dosing
S-Bioallethrin 1 2 1
Permethrin 1.5 2 1
Cypermethrin 1.5 2 2
Deltamethrin 2 2 2
Esfenvalerate 2 2 2
β-Cyfluthrin 2 2 2
Fenpropathrin 2 2 2
Tefluthrin 2 2 2
λ-Cyhalothrin 2.5 2 2
Bifenthrin 4 2 4
Resmethrin 4 2 4Wolansky et al.
1566  v o l u m e  117 | n u m b e r 10 | October 2009  •  Environmental Health Perspectives
individual chemicals (i = 1, . . . , 11), and 
δ is the threshold parameter such that the 
dose threshold for each individual chemical 
is given by δi = δ/βi, i = 1, . . . , 11. The γ 
parameter was constrained to be γ = 100 – α, 
so that the mean response for the vehicle-
control groups is 100%. It is important to 
note that the form of the additivity model 
does not include information about schedul-
ing of dosing, because single-chemical data 
were available only with the SLT protocol. 
Therefore, for the present study we assumed 
that the model represented by Equation 2a 
is an additivity model for the case where the 
timing of the dosing has a negligible effect.
When the dose thresholds for all single 
chemicals are estimated outside of the experi-
mental region, the model in Equation 2a is 
over  parameterized. The corresponding non-
linear smooth additivity model is given by
  exp x µ ii
i 1
11
add ac b =+
=
fp / .  [2b]
We estimated unknown parameters 
using the maximum quasi-likelihood method 
(McCullagh and Nelder 1989). The esti-
mated additivity model was used to predict 
the mean response along the fixed mixing 
ratio of the 11 chemicals in terms of total 
dose. Threshold estimates, ED30 values, ED10 
values (i.e., the response associated with a 
10% motor activity decrease), and the cor-
responding large-sample 95% confidence 
intervals (CIs) for each single chemical were 
computed, as well as dose thresholds, ED10 
values, and ED30 values for the mixture. In 
this work, all of these parameter estimates 
were computed using empirical data from 
single compounds and mixtures. However, 
for single chemicals, dose thresholds, ED30 
values, and RPFs for motor function had 
been previously obtained using the same SCR 
model parameterized using only experimen-
tal data from single compounds (Wolansky 
et al. 2006). All 11 chemicals in this study 
are associated with significant decreases in 
motor activity as their doses increase, as 
evidenced by negative and significant slope 
parameters. The significance of the thresholds 
can be described by the significance of the 
threshold parameter (δadd) in the additiv-
ity model (p < 0.001) and the 95% CIs on 
the dose thresholds that did not include zero 
(Wolansky et al. 2006). We estimated the 
curve for the mixture dose–response relation-
ship using the model expressed by 
µ =
=
t > a c i d +
a c +
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which is associated with the threshold additiv-
ity model given in Equation 2a, or
  µ = α + γ exp(θadd t),  [3b]
which is associated with the nonlinear additivity 
model given in Equation 2b.
Thus, the slope parameter associated with 
mixture along the specified fixed-ratio ray 
under additivity is
  a
1
11
addi i
i
ib =
=
/ .
By replacing the unknown parameters 
in Equations 3a and 3b with parameter esti-
mates, a plot of the dose–response curve 
under additivity for a specified fixed ratio of 
the chemicals was produced. The predicted 
mixture dose–response relationship was 
estimated using only single-chemical dose– 
response data (Equation 2) and then predict-
ing along the mixture ray with the constraint 
of additivity given in Equation 1.
Following Gennings et al. (2002) and 
Casey et al. (2004), the mixture data along the 
fixed mixture ray is fit to a similarly param-
eterized mixture model of the form
 µ exp t
t
t
>
mix m ix
mix m ix
mix m ix
mix #
a c
a c i d
i d
i d =
+
+ - ^ h
* 4  [4]
for a threshold model. The hypothesis of addi-
tivity along the specified ratio of the chemicals 
is a hypothesis of coincidence (i.e., the rela-
tionships are the same) between the additivity 
model in Equation 2 and the mixture model 
given in Equation 4 (i.e., for the threshold 
additivity models),
H0: {imix = iadd and dmix = dadd} versus 
H1: {imix ≠ iadd or dmix ≠ dadd}.  [5]
To determine whether there was a statisti-
cally significant deviation from additivity, we 
used a quasi-likelihood ratio test to compare 
the empirical mixture model with the restricted 
additivity model based on an F-distribution 
(e.g., Casey et al. 2004). The restricted addi-
tivity model (Casey et al. 2004) included only 
the single-chemical dose–response model 
parameters but used both the single-  chemical 
and mixture data. We used this restricted 
model to predict the mean responses for the 
mixture data using the constraint of additiv-
ity given in Equation 1. Finally, we compared 
the predicted responses from the mixture data 
under the hypothesis of additivity (Casey et al. 
2004; Gennings et al. 2002) with the observed 
sample means using an F-test.
Results
We observed no mortality in the experiments 
in this study. The two higher mixture dosages 
(i.e., 76.2 and 152.4 mg/kg) evoked few clinical 
signs of pyrethroid toxicity. Mild whole-body 
tremors were present in most animals at the 
highest mixture dose (152.4 mg/kg) from 1 to 
4 hr post  dosing. Signs of high-dose pyrethroid 
toxicity such as excessive salivation, whole-
body tremors, and choreo  athetotic movements 
(Aldridge 1990; McDaniel and Moser 1993; 
Soderlund et al. 2002) were not observed in 
any animals, with one exception: One rat in 
the time-course experiment exhibited clini-
cal signs of excessive pyrethroid exposure and 
raspy breath sounds, possibly due to partial 
aspiration of the gavage solution into the lungs. 
Data from this animal were not used.
The time-course study revealed a rapid 
decline in motor activity with a peak decrease 
at 1–2 hr post  dosing (Figure 1). Activity recov-
ered to control levels at 24–48 hr post  dosing. 
The time course of effects was similar for both 
mixture-dose groups. These conclusions were 
Table 3. Estimated model parameters from the 
threshold additivity model (Equation 2a) and the 
mixture model (Equation 3a) fit simultaneously.
Parameter Estimates SE p-Value
Single-chemical slope parameters
 α 26.49 2.14 < 0.001
 β  1 (β-cyfluthrin) –0.283 0.04 < 0.001
 β  2 (bifenthrin) –0.196 0.031 < 0.001
 β  3 (S-bioallethrin) –0.0069 0.0011 < 0.001
 β  4 (cypermethrin) –0.058 0.013 < 0.001
 β  5 (deltamethrin) –0.248 0.053 < 0.001
 β  6 (esfenvalerate) –0.529 0.105 < 0.001
 β  7 (fenpropathrin) –0.081 0.012 < 0.001
 β  8 (λ-cyhalothrin) –0.479 0.073 < 0.001
 β  9 (permethrin) –0.015 0.0018 < 0.001
 β  10 (resmethrin) –0.0022 0.0003 < 0.001
 β  11 (tefluthrin) –0.274 0.043 < 0.001
Mixture slope parameters
 θ 1 (SLT) –0.016 0.004 < 0.001
 θ 2 (SQT) –0.015 0.003 < 0.001
Threshold parameters
 δ add –0.262 0.077 < 0.001
 δ mix_1 (SLT) –0.307 0.303 0.31
 δ mix_2 (SQT) –0.08 0.102 0.433
Data are the estimated slopes for single chemicals 
(β parameters) and the mixture (θ parameters) adminis-
tered using two alternative dosing protocols (i.e., SLT and 
SQT protocols), and the estimated thresholds (δ parame-
ters) for the additivity model (δadd) and the two dosing 
protocols (δmix_1 and δmix_2). 
Figure 1. Time course of cumulative effects of 
11 pyrethroids on figure-eight maze activity (mean 
± SE). The arrow indicates the time of peak effects 
for the tested mixture. 
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supported by a significant mixture-dose × time 
interaction [F(10,147) = 5.18, p < 0.0001] 
and significant main effects of mixture dose 
[F(2,147) = 62.48, p < 0.0001] and testing 
time [F(4,147) = 15.5, p < 0.0001]. The activ-
ity of all mixture-dose groups was significantly 
decreased compared with controls at 1, 2, 4, 
and 8 hr (p < 0.05).
Parameter estimates and correspond-
ing p-values from the additivity model in 
Equation 2a, from the simultaneously fit 
single-chemical data and mixture data, are 
provided in Table 3. The slope parameters 
associated with each of the 11 single chemi-
cals (β values) and for the fixed-ratio mixtures 
(θ values) were negative and significant, 
indicating that as the dose of each individ-
ual chemical or the total dose of the mixture 
increases, the mean motor activity decreases.
Figure 2 shows the plots of individual 
data points for each chemical and the fit dose 
response using the additivity model. These 
plots illustrate the wide potency range of the 
individual chemicals, from 10 to 900 mg/kg,   
and the dose-related decrease in activity 
for all 11 chemi  cals. These plots also illus-
trate the estimated thresholds for each of 
the dose–response functions. Table 3 lists 
the estimated model parameters from the 
threshold additivity model and the mixture 
model fit simultaneously. The simultaneous 
fit of the additivity model and the mixture 
model accommodates a common maximum 
effect parameter (α), which was estimated 
to be 26.5 (i.e., 26.5% of control; Table 1). 
The γ parameter was constrained to be 
γ = 100 – α, so that the mean response for 
the control groups is 100%. Tables 4 and 5 
list the model estimates for the threshold 
dose and ED30 dose. Note that the individual 
chemical estimates in Tables 3–5 are in some 
cases marginally different than previously 
published estimates (Wolansky et al. 2006) 
because of the inclusion of the mixtures data 
in the SCR model in the present study: The 
Figure 2. Observed data (individual data points) and the model-predicted dose–response curve from the additivity threshold model given in Equation 2a for each 
of the 11 pyrethroids. 
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empirical mixtures data were not available for 
inclusion at the time the previous estimates 
were published.
The mixture dose–response studies demon-
strated dose-related decreases in activity regard-
less of the dosing protocol (Figure 3). For the 
SQT group, the pyrethroid mixture decreased 
activity by approximately 58% in the two 
highest mixture-dose groups, with significant 
decreases in all mixture doses ≥ 30.4 mg/kg 
(p < 0.05). There was no interaction between 
testing block and mixture dose [F(14,92) = 0.66, 
p < 0.8030], but there were significant main 
effects of dose [F(7,92) = 12.84, p < 0.0001] 
and block [F(2,92) = 6.15, p < 0.0035]. The 
main effect of block was due to slight differ-
ences in the overall baseline for activity counts 
over the different test days (data not shown). 
For the SLT protocol, the pyrethroid mixture 
decreased activity by 60% in the highest mix-
ture-dose group, with significant decreases in all 
mixture doses ≥ 50.2 mg/kg (p < 0.05). There 
was no interaction between testing block and 
mixture dose [F(14,94) = 1.24, p < 0.2643], 
but there were significant main effects of 
dose [F(7,94) = 20.45, p < 0.0001] and block 
[F(2,94) = 2.85, p < 0.0414]. Because of the 
lack of interaction between replicate testing 
blocks and mixture dose, and the significant 
main effect of replicate block, we conducted all 
additional analyses on the motor activity counts 
expressed as percentage of block control values.
Results of the SCR method demonstrated 
no significant difference between the predicted 
response and the empirical data for both the 
SLT and SQT exposure protocols. Table 3 lists 
the slope estimates for individual chemicals 
and the dosing protocols, as well as the thresh-
old estimates for both protocols. The empirical 
fit for the mixture administered using the SLT 
protocol was not different from that predicted 
assuming additivity, and the null hypothe-
sis was not rejected [F(2,1037) = 0.015, 
p = 0.985; Figure 3A]. The small shift to 
the left in the dose–response relationship 
between the empirical and predicted curves 
for the SQT protocol (Figure 3B) was not 
significant, and the null hypothesis was not 
rejected [F(2,1037) = 2.65, p = 0.071]. The 
two thresholds were not statistically different; 
however, the SQT protocol threshold value 
(5.38 mg/kg) was 3.7-fold lower than that 
using the SLT protocol (19.82 mg/kg). This 
difference was 1.5-fold when we compared 
mixture ED30 values (SQT, 29.27 mg/kg, 
vs. SLT, 49.81 mg/kg). The CIs were wide 
and included zero, and although the thresh-
old for the mixture administered using the 
SQT dosing protocol was numerically lower 
than that for the mixture where the chemi-
cals were administered together at once 
(see Figure 3A,B), a test of coincidence 
in the two mixture curves was not rejected 
[F(2,1037) = 0.90, p = 0.407; Table 3].
Discussion
In the present study we tested the hypothe  sis 
that the combined action of 11 pyrethroid 
insecticides on motor function is predicted 
by dose addition. We designed the mixture 
so that the highest mixture dose contained 
doses of each pyrethroid that were below their 
individual thresholds for effect. The results 
demon  strated that the additivity model pre-
dicted the measured effects on behavior in 
rats. The present results provide the first 
in vivo evidence on cumulative actions of 
pyrethroid mixtures in mammals. These data 
suggest that dose-additive approaches should 
be used when assessing the risk of exposures to 
chemical mixtures that contain pyrethroids.
The time course of effect of the pyrethroid 
mixture was consistent with patterns reported 
for a number of single-compound assessments. 
The time course for the mixture showed a 
maximum decrease in activity at 1–2 hr and 
recovery within 24–48 hr. Previous reports 
from studies using similar dosing protocols 
in rats demon  strated maximal decreases in 
figure-eight maze activity at 1–4 hr post  dosing 
(Crofton et al. 1995; Crofton and Reiter 
1984, 1988; McDaniel and Moser 1993; 
Wolansky et al. 2006). In addition, allethrin, 
S-bioallethrin, permethrin, fenvalerate, delta-
methrin, and cypermethrin evoke altera-
tions in motor-related end points in small 
rodents evident as early as 0.5–1.5 hr after 
systemic exposure (De Souza Spinosa et al. 
1999; Hoy et al. 2000; McDaniel and Moser 
1993; Nishimura et al. 1984; Wolansky et al. 
2006). Likewise, the extended effect on activ-
ity through 8 hr is consistent with the pro-
longed syndromes evoked by resmethrin and 
bifenthrin (Crofton and Reiter 1984; Holton 
et al. 1997; Soderlund et al. 2002; White 
et al. 1976; Wolansky et al. 2006, 2007). 
Reports of longer times to onset after acute 
exposures (e.g., Soderlund et al. 2002) have 
been attributed to larger dosing volumes that 
delay absorption (Kim et al. 2007; Wolansky 
et al. 2007). The present data are also consis-
tent with the fact that most of the 11 chemi-
cals have individual times to peak effects of 
1.5–2.5 hr post  exposure (Table 2). These data 
support the hypothesis that the toxico  kinetics 
of pyrethroids may not be altered in mixtures 
composed of low-levels of the individual insec-
ticides. Toxicokinetic studies of pyrethroid 
mixtures are needed to test this hypothesis.
The mixture of 11 pyrethroids produced 
dose-dependent decreases in motor activ-
ity. This is consistent with previous reports 
of dose-related decreases in activity in the 
Table 4. Estimated dose thresholds for each of the 
11 chemicals with 95% large sample CIs.
Chemical
Threshold 
estimatea SE 95% CI
β-Cyfluthrin 0.93 0.22 0.50 to 1.36
Bifenthrin 1.34 0.32 0.70 to 1.97
S-Bioallethrin 38.09 8.29 21.82 to 54.36
Cypermethrin 4.48 1.20 2.12 to 6.84
Deltamethrin 1.06 0.29 0.50 to 1.62
Esfenvalerate 0.50 0.13 0.25 to 0.75
Fenpropathrin 3.25 0.70 1.87 to 4.62
λ-Cyhalothrin 0.55 0.13 0.29 to 0.81
Permethrin 18.04 4.05 10.09 to 26.00
Resmethrin 121.64 25.68 71.25 to 172.03
Tefluthrin 0.96 0.22 0.52 to 1.40
Mixture 1 (SLT) 19.82 14.60 –8.83 to 48.47
Mixture 2 (SQT) 5.38 6.20 –6.78 to 17.54
aThreshold values for the individual chemicals vary 
slightly from those in Table 1 because of inclusion of the 
single-chemical and mixture data in the computation of 
the estimates (see “Materials and Methods” for details). 
Table 5. Estimated ED30 values for each of the 
11 chemicals with 95% large-sample CIs.
Chemical
ED30 
estimate SE 95% CI
β-Cyfluthrin 2.19 0.26 1.69 to 2.69
Bifenthrin 3.16 0.42 2.34 to 3.99
S-Bioallethrin 89.88 10.8 68.6 to 111.1
Cypermethrin 10.57 2.05 6.55 to 14.60
Deltamethrin 2.50 0.48 1.56 to 3.44
Esfenvalerate 1.17 0.20 0.78 to 1.57
Fenpropathrin 7.66 0.81 6.06 to 9.26
λ-Cyhalothrin 1.29 0.17 0.96 to 1.62
Permethrin 42.57 4.03 34.7 to 50.5
Resmethrin 287.03 30.7 226.7 to 347.4
Tefluthrin 2.26 0.29 1.70 to 2.83
Mixture 1 (SLT) 42.81 9.58 24.0 to 61.6
Mixture 2 (SQT) 29.27 4.52 20.4 to 38.1
Figure 3. Dose–response relationships for the cumulative effects of 11 pyrethroids on figure-eight maze 
activity (mean ± SD). (A) SLT group. (B) SQT group. The departure of the experimental data from the pre-
dictive curve modeled assuming dose addition was not significant. 
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figure-eight maze in rats (Crofton et al. 1995; 
Crofton and Reiter 1984, 1988; Gilbert et al. 
1990; McDaniel and Moser 1993; Reiter et al. 
1981) and in other assessments with motor 
end points carried out in mice (Chanh et al. 
1984; Mandhane and Chopde 1997). Thus, 
decreased locomotor behavior appears as a 
common finding of acute pyrethroid exposure 
to both individual compounds and mixtures.
An important finding of the present study 
is that low doses of the individual chemi  cals, 
when combined in a mixture, decreased motor 
activity. The threshold for decreased activ-
ity was 5.4 mg total pyrethroids/kg when the 
SQT protocol was used (Figure 3). The abso-
lute amount of each individual pyrethroid at 
this mixture dose is approximately 3% of the 
threshold dose for altering motor activity when 
given alone in the single-compound assays 
(Table 1). These data clearly demonstrate two 
key findings. First, that effect addition, defined 
as a simple summation of the effects (i.e., sum 
of decreases in motor activity) of all chemicals 
in a mixture, under  estimates the potency of the 
tested mixture by a wide margin. Second, these 
data demon  strate that low doses of individual 
pyrethroids, when acutely administered as a 
mixture, produce measurable effects on motor 
behavior in the rat.
We used the mixture experiments pre-
sented here to test two hypotheses. The first 
hypothesis, that the SCR threshold additiv-
ity model would predict the effects of an   
11-pyrethroid mixture, was not rejected. 
There was no significant deviation between 
the predicted and empirical fits for data 
from either the SLT or SQT dosing proto-
cols (Figure 3). Thus, dose addition can be 
used as a means to predict the effects of pyre-
throid mixtures on motor activity. The second 
hypothesis, that kinetic differences between 
pyrethroids would lead to different effects if 
the individual pyrethroids were dosed accord-
ing to the time of peak effect, was rejected. 
The model predicted the empirical effects of 
the 11-pyrethroid mixture for both the SLT 
and SQT protocols. These data are the first 
demonstration that dose addition correctly 
predicts the neuro  toxic effects of a pyrethroid 
mixture composed of low-level, equitoxic 
doses of the individual chemicals.
The finding of dose addition for the 
11 tested pyrethroids is consistent with a com-
mon target site, the voltage-gated sodium chan-
nel (Narahashi 2000; Soderlund et al. 2002). 
However, these results are not consistent with 
previous reports on exposures to multiple 
pyrethroids. Ray et al. (2006), using an in vivo 
hippocampal electro  physiologic model, demon-
strated that delta  methrin and bioresmethrin 
did not act in an effect-additive or antagonistic 
manner. Burr and Ray (2004), using excised 
membrane patches from a neuro  blastoma cell, 
showed that some combinations of type I and 
type II pyrethroids may compete for binding 
to a Cl– channel target site. Furthermore, these 
authors reported that binary mixtures did not 
lead to effect-additive outcomes. Song and 
Narahashi (1996) concluded that tetramethrin 
may displace fenvalerate or interact allosteri-
cally with sodium-channel protein binding sites 
in an ex vivo rat dorsal root ganglion prepara-
tion. Although these reports suggest that pyre-
throids do not act in an effect-additive manner, 
the experimental designs used preclude any 
definitive conclusions concerning additivity 
from these reports. First, the electro  physiologic 
work (Ray et al. 2006) used dose levels that 
exceeded known lethal doses. In addition, all 
of these previous reports lacked, either by study 
design or by statistical approach, the ability 
to test the hypothesis of additivity. The use of 
rigorous statistical models is critical for testing 
hypothe  ses of effect addition or dose addition 
and determining whether antagonism or syner-
gism exists (Feron and Groten 2002; Gennings 
et al. 2004; Hertzberg and Teuschler 2002; 
LeBlanc and Olmstead 2004; Teuschler 2007). 
The finding of dose addition for both the 
SLT and SQT protocols suggests a lack of 
toxico  kinetic or enzymatic interactions at low 
doses, which has been shown for other mix-
tures (El-Masri et al. 1996a, 1996b, 2004). 
Alternatively, the present model may be 
unable to detect deviations from dose addition 
that might result from exposure to a complex 
mixture where most of the chemicals have 
similar time courses of effect. As shown in 
Table 2, 9 of the 11 pyrethroids had times of 
peak effect between 1 and 2.5 hr. The scar-
city of toxico  kinetic models for pyrethroids 
(Mirfazaelian et al. 2006) and the absence of 
any mixture models preclude any definitive 
conclusion on this issue. However, the present 
findings clearly indicate that small differences 
in the time of administration did not affect 
measured outcome (i.e., general motor func-
tion output in a maze).
The extrapolation of these findings to 
human exposures is currently tempered by a 
number of uncertainties. Humans are routinely 
exposed to multiple pyrethroids; however, con-
current exposures may be limited to only a 
small number of pyrethroids (Lu et al. 2009; 
Tulve et al. 2008), nowhere near the simulta-
neous exposure to 11 pyrethroids used here. 
In addition, the composition of the 11-chem-
ical mixture was based on individual chemical 
potency (Table 1), not on environmental expo-
sures. Whether other mixtures with a smaller 
number of chemicals and different chemical 
ratios will be dose additive is unknown.
Extrapolation of the present findings to 
humans is also hampered by an inability to 
compare exposures between species. The pres-
ent work employed acute oral gavage expo-
sures to rats. Human exposures from dietary 
and environmental residues are likely to be 
much lower compared with the rat acute oral 
exposures used in the present study. Acute 
oral bolus doses may result in higher peak tis-
sue concentrations, compared with dietary 
and dermal human exposures (Conolly et al. 
1999). Urinary levels of pyrethroid metabo-
lites range from non  detectable to as high as 
50 µg/L, with median levels between 1 and 
5 µg/L (Lu et al. 2009; Morgan et al. 2007). 
Comparable data are not available in rats. 
Toxicokinetic models are needed that will 
allow comparison between effective doses in 
rats and aggregate human exposures.
Conclusions
In summary, the present data demonstrate 
that sub  threshold doses of individual pyre-
throids, when combined in a mixture, pro-
duce measurable neurotoxicity in rats. These 
findings provide the first in vivo evidence of 
cumulative actions of pyrethroid mixtures 
in mammals and suggest that dose-additive 
approaches should be used for considering the 
combined toxicity of pyrethroid insecticides.
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